Partners and Affiliates
The CNDD is a multidisciplinary and collaborative effort with a number of other departments and organizations – both within UNC-Chapel Hill and beyond.
Within UNC-Chapel Hill
Many faculty at the UNC Eshelman School of Pharmacy have joint memberships in LCCC, one of the leading cancer centers in the nation. As one of forty-one National Cancer Institute-designated comprehensive cancer centers, UNC Lineberger brings together some of the top physicians and scientists in the country to investigate and improve the prevention, early detection and treatment of cancer.
CICBDD brings dedicated medicinal-chemistry expertise to bear on biological targets of therapeutic relevance under investigation by UNC faculty. The center uses medicinal chemistry, assay development, compound profiling, and computational chemistry tools to design, synthesize, and test small molecules against biological targets.
CPIT focuses on approaches that utilize genetic information in selecting the right drug, together with the right dose and administration schedule, at the onset of treatment for each individual patient.
CCECR uses advanced computational chemistry and molecular modeling tools to support experimental projects, data management, analysis, and experimental design.
Institute for Advanced Materials, Nanoscience and Technology (IAM)
IAM, directed by Dr. DeSimone, is an interdisciplinary institute, coordinating research efforts across the internationally recognized strengths of UNC-Chapel Hill in polymer science, nanomaterials, and nanobiosciences.
CCNE is an NCI-funded multidisciplinary collaboration among a range of disciplines including departments of Pharmacy, Radiation Oncology, Chemistry, Genetics, Radiology, Hematology/Oncology, Microbiology & Immunology and Lineberger Comprehensive Cancer Center.
Beyond UNC- Chapel Hill
The CDDN unifies existing diverse technical and scientific expertise in biomedical and material science research at the University of Nebraska to create a world-class interdisciplinary drug delivery and nanomedicine program. The CDDN integrates established expertise in drug delivery, gene therapy, neuroscience, pathology, immunology, pharmacology, vaccine therapy, cancer biology, polymer science and nanotechnology at the University of Nebraska Medical Center, the University of Nebraska at Lincoln, and Creighton University.